RSS
1 Apr 2022

Alcresta Therapeutics Announces Series of Commercial Milestone Achievements for RELiZORB®

Author: admintech | Filed under: Press Release

NEWTON, Mass., April 1, 2022 /PRNewswire/ — Alcresta Therapeutics, Inc., a leading commercial-stage company focused on developing and commercializing novel enzyme-based products, today announced a series of commercial milestone achievements. Alcresta announced its first profitable year…

This entry was posted on Friday, April 1st, 2022 at 7:10 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»